Skip to content

Dual-scopic Pancreatic Necrosectomy (DPN)

Dual-scopic Pancreatic Necrosectomy (DPN): Laparoscopic Pancreatic Necrosectomy (LPN) and Nephroscopic Pancreatic Necrosectomy (NPN)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04443595
Enrollment
20
Registered
2020-06-23
Start date
2020-07-01
Completion date
2025-12-31
Last updated
2020-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Diseases, Pancreatitis, Pancreatitis, Acute Necrotizing

Brief summary

The LPN procedure is performed under general anesthesia. The transperitoneal access to peripancreatic space is via the gastro-colic ligament and greater omentum, effusion and pus is removed by laparoscopic forceps and suction. Laparoscopic cholecystectomy (LC) is performed during the LPN procedure on patients with indication. The NPN procedure is followed by the standard retroperitoneal approach. After the catheter is exchanged over a guide wire and serially dilated up from 6F to 24F followed by Seldinger technique, the access track to the necrotic cavity is established. A nephroscope is inserted into the cavity through the track for debridement. Using forceps and suction, the peripancreatic solid necrotic tissue and pus is grasped and removed. A large-bore irrigating drain is left in the cavity, with continuous irrigation by warm normal saline solution at a rate of 100-125 ml/h after surgery.

Interventions

PROCEDUREDual-scopic pancreatic necrosectomy(DPN)

Treatment of Acute Severe Pancreatitis with DPN

Sponsors

First People's Hospital of Hangzhou
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients ages 18 or above admitted to UPMC with a diagnosis of AP based on at least 2 of the following criteria:(i) abdominal pain characteristic of AP (ii) serum amylase and/or lipase ≥ 3 times the upper limit of normal (iii) characteristic findings of AP on abdominal CT scan will be screened for study enrollment.

Exclusion criteria

* Less than 18 years of age * Pregnant women * Presence of renal dysfunction (Cr\>1.5mg/dL) * Pre existing heart dysfunction or NYHA classification score above III * Coagulation disorder

Design outcomes

Primary

MeasureTime frameDescription
Complication Ratethrough study completion, an average of 24 weeksProportion of patients with perioperative complications
Mortalitythrough study completion, an average of 24 weeksProportion of patients dying in the perioperative period

Secondary

MeasureTime frameDescription
Hospital staythrough study completion, an average of 24 weeksLength of hospital stay

Countries

China

Contacts

Primary ContactYang Cai
caiyang6969@163.com+8613867136969

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026